Private equity firm Inflexion has acquired a minority stake in European LifeCare, Europe’s largest provider of vaccinations.
European LifeCare Group (ELCG) was founded in 1998 and now has over 50 specialist clinics in Denmark and the UK where the company trades under a number of brands, including London Travel Clinic.
ELCG also works for both the Danish and English NHS as a contracted service provider of immunisation programmes in schools and national influenza vaccination programmes.
The business is forecast to vaccinate approximately 400,000 individuals in 2018 on behalf of the NHS in Denmark and the UK.
Inflexion’s investment will be used to support a rapid buy-and-build programme by ELCG which plans to double the number of clinics it has over the next few years.
Simon Turner, Managing Partner of Inflexion, said: “ELCG is a leading company in a rapidly growing niche market. The team have strong experience in building their business both through acquisitions and opening new clinics. They are the number one consolidator in a fragmented market which also has scope to benefit from additional clinic openings. We look forward to working with them to accelerate ELCG’s already impressive growth.”
Karsten Østergaard, CEO and Co-Founder of ELCG, added: “We are proud of the company we have built, and now see a tremendous opportunity to accelerate our UK growth where we see the potential for over 100 of our vaccination clinics. Inflexion’s strong track record in sourcing and integrating add-on acquisitions makes them an excellent partner for us as we embark on this next phase of our journey.”